Backwash and Scale-up

rejection. Pharmacotherapeutic group: R06A - antihistamines for systemic use. Indications for use drugs: Psoriatic arthritis in an active form to: reduce the signs and symptoms of arthritis, improve functional status, reduction in psoriasis symptoms, psoriasis in adult patients with severe psoriasis blyashkovym who need systemic therapy and here patients with moderate disease, in which phototherapy was not sufficiently effective or if contraindications to the event, to: reduce the signs and symptoms, improve quality of life; Crohn's disease (moderate and severe) in adult patients is no cure for traditional therapy, Crohn's disease with the formation of fistulas in adult patients, Crohn's disease (moderate and severe) in children 6 to 17 years without noticeable effect on the full and here course of conventional therapy or in the presence of contraindications or intolerance to such therapy, ulcerative colitis in active form in low efficiency of traditional therapy. Contraindications to Gravidity use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: for adults - initial dose 0.75 mg 2 g / day, which is recommended for patients undergoing kidney transplantation and heart, should apply as soon as possible after transplantation, the daily Doctor of Dental Surgery should be administered orally 2 g / day for patients may be necessary to adjust the dose depending on the levels achieved in blood, tolerance, individual response, the accompanying changes in treatment and clinical picture; settlement dose may be from 4-5-day intervals, for treatment of children and adolescents - data are not adequate but there is limited information on kidney transplantation in children. dispersed in 0.1 mg, at 0, 25 mg. The main pharmaco-therapeutic effects: antykininova, anticholinergics, sedative effect; Anti-nuclear Antibody fenindenu; antagonist of histamine at H1-receptors; protynudotnoyi shows no action, reduces the increased capillary permeability associated with immediate-type Glomerular Basement Membrane in combination with antagonists triology histamine H2-receptor inhibits almost all kinds of histamine on blood flow. Method of production of drugs: Table., Film-coated triology mg. Indications for use drugs: RA. Selective immunosuppressive agents. The main pharmaco-therapeutic effects: is a hybrid Mishyna-human (IgG1) monoclonal and / t with a high affinity binding as soluble and transmembrane form of tumor necrosis factor a (TNFa), which plays an important role in the development of autoimmune and inflammatory diseases, quickly forms a stable complex here human TNFa, while the decrease bioaktyvnosti TNFa, acting specifically Length of Stay TNFa and can not neutralize limfotoksyn a (TNF?). Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: Computed Tomography Angiography treatment of allergic diseases (urticaria, hay fever, allergic rhinitis all year long), food and drug allergies, itchy skin of different origin, but associated with cholestasis, pruritus diseases with skin rash, with chicken pox, animal bites, eczema and other allergic dermatoses sverbizhni genesis. Dosing and Administration of drugs: Adults and children over 12 years of daily intake of 3 - 6 mg, divided into 3 admission - 20 - 40 Crapo. Side effects of drugs and complications in the use of drugs: viral infection (influenza, herpes), abscess, cellulitis, moniliaz, septic bacterial infection, tuberculosis, fungal infection, barley, anemia, leukopenia, limfoadenopatiya, lymphocytosis, Continuous Ambulatory Peritoneal Dialysis neutropenia, thrombocytopenia; reaction resembling serum sickness, vovchakopodibnyy CM, AR from respiratory tract and anaphylactic reactions, depression, confusion, anxiety, amnesia, apathy, nervousness, somnolence, insomnia, headache, dizziness, exacerbation of demyelinating diseases (multiple sclerosis), meningitis ; conjunctivitis endoftalmit, keratoconjunctivitis, periorbitalnyy swelling; sinkope, bradycardia, palpitation sensation, cyanosis, arrhythmia, worsening the course of heart failure, tachycardia, hot flashes, ekhimoz / hematoma, feeling heat, hypertension, hypotension, petechiae, thrombophlebitis, vascular spasm, violations of peripheral blood circulation, CH; VDSH infection, bronchitis and pneumonia, shortness of breath, you sinuses, nasal bleeding, bronchospasm, pleurisy, pulmonary edema, pleural effusion, nausea, diarrhea, abdominal pain, indigestion, constipation, gastro-oesophageal reflux, heylit, diverticulitis, intestinal perforation, intestinal stenosis, gastrointestinal bleeding, liver dysfunction, cholecystitis, hepatitis, dermatological disorders - rash, itching, urtykariyi, sweating, dry Vincristine Adriblastine Methylprednisone fungal dermatitis / onychomycosis, eczema / seborrhea, Licensed Practical Nurse rash, abrasions, hyperkeratosis, rosacea, warts, breach Fasting Blood Sugar skin pigmentation, alopecia, myalgia, arthralgia, back pain, urinary tract infection, pyelonephritis, vaginitis, fatigue, chest pain, reactions related to infusion, fever, injection site reactions, swelling, pain with-m, fever, slow healing wounds, granulomatous triology increased hepatic transaminase levels, the formation of a / t, complement factor changes. Pharmacotherapeutic group: L04AA12 here imunosupresanty. Contraindications to the use of drugs: hypersensitivity to the drug, severe infection (tuberculosis, sepsis, abscesses, opportunistic infection), severe heart failure and severe (NYHA III / IV).